NR 546 Advanced Pharmacology Psychopharmacology
for the Psychiatric-Mental Health Nurse Practitioner
Midterm Exam Week 4
1. How does the orbitofrontal cortex (OFC) affect the amygdala?: inhibits andactivates
the amygdala
2. Wernicke's area is associated with which of the following?: speech compre-hension
3. The limbic system is associated with which of the following: emotion andlearning
4. Which brain structure is most associated with long term memory?: hip-pocampus
5. When prescribing psychotropic medications, the PMHNP knows that these
,medications work within which specific areas?: mood
6. Which of the following are involved in regulating neurotransmission via ex- citation-
secretion coupling?: voltage-sensitive sodium channels and voltage-sen- sitive calcium
channels
7. What system influences the length of time for a drug to achieve efficacy?: -
signal transduction cascades
8. One of the signal transduction cascades, pass the message from a firstreceptor to
a second messenger.: G protein linked systems
9. Human central nervous system communication at synapses is which of the
following?: chemical
10. Which of the following is an excitatory neurotransmitter?: glutamate
11. Which statement correctly pairs the pharmacodynamic effect with its defi-nition?:
antagonist effect - drug binds to receptor, but does not activate a response
, 12. A major current hypothesis for the cause of schizophrenia proposes thatN-methyl-
d-aspartate (NMDA) receptors may be which of the following? Correct!: hypofunctional
13. Which medication is least associated with weight gain?: aripiprazole
14. Which dopamine pathway is associated with positive symptoms of schiz-
ophrenia?: mesolimbic pathway
15. Which pathway is associated with negative symptoms?: The mesocorticalpathway
16. Is part of the extrapyramidal nervous system and associated with ex-
trapyramidal symptoms (EPS): nigrostriatal pathway
17. This pathway is associated with hyperprolactinemia.: The tuberoinfundibu-lar
pathway
18. A 34-year old male recently began experiencing breast secretions while receiving
risperidone . Which dopamine pathway is associated with this sideeffect?:
tuberoinfundibular pathway
for the Psychiatric-Mental Health Nurse Practitioner
Midterm Exam Week 4
1. How does the orbitofrontal cortex (OFC) affect the amygdala?: inhibits andactivates
the amygdala
2. Wernicke's area is associated with which of the following?: speech compre-hension
3. The limbic system is associated with which of the following: emotion andlearning
4. Which brain structure is most associated with long term memory?: hip-pocampus
5. When prescribing psychotropic medications, the PMHNP knows that these
,medications work within which specific areas?: mood
6. Which of the following are involved in regulating neurotransmission via ex- citation-
secretion coupling?: voltage-sensitive sodium channels and voltage-sen- sitive calcium
channels
7. What system influences the length of time for a drug to achieve efficacy?: -
signal transduction cascades
8. One of the signal transduction cascades, pass the message from a firstreceptor to
a second messenger.: G protein linked systems
9. Human central nervous system communication at synapses is which of the
following?: chemical
10. Which of the following is an excitatory neurotransmitter?: glutamate
11. Which statement correctly pairs the pharmacodynamic effect with its defi-nition?:
antagonist effect - drug binds to receptor, but does not activate a response
, 12. A major current hypothesis for the cause of schizophrenia proposes thatN-methyl-
d-aspartate (NMDA) receptors may be which of the following? Correct!: hypofunctional
13. Which medication is least associated with weight gain?: aripiprazole
14. Which dopamine pathway is associated with positive symptoms of schiz-
ophrenia?: mesolimbic pathway
15. Which pathway is associated with negative symptoms?: The mesocorticalpathway
16. Is part of the extrapyramidal nervous system and associated with ex-
trapyramidal symptoms (EPS): nigrostriatal pathway
17. This pathway is associated with hyperprolactinemia.: The tuberoinfundibu-lar
pathway
18. A 34-year old male recently began experiencing breast secretions while receiving
risperidone . Which dopamine pathway is associated with this sideeffect?:
tuberoinfundibular pathway
